Literature DB >> 2461538

Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease.

M Schluep1, A J Steck.   

Abstract

We demonstrated the binding of an IgM monoclonal protein, obtained from a patient with motor neuron disease, with known antibody activity against gangliosides GM1, GD1b, and asialo GM1, to neuromuscular junctions in guinea pig gastrocnemius muscle, using an indirect immunofluorescence technique. Staining disappeared after delipidation of muscle sections. Denervated muscle sections showed no labeling at the neuromuscular junction after incubation with the patient's serum. This indicates presynaptic binding of the IgM M protein and supports the concept that IgM monoclonal antibody to nerve terminal determinants may underlie a motor neuron disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461538     DOI: 10.1212/wnl.38.12.1890

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

2.  A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.

Authors:  J Zielasek; G Ritter; S Magi; H P Hartung; K V Toyka
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

3.  Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.

Authors:  Rumi Sato; Shiho Imamoto; Iku Utsnomiya; Terumasa Chiba; Kyoji Taguchi; Kenji Abe; Keiko Tanaka; Tadashi Miyatake
Journal:  Neurol Sci       Date:  2013-02-07       Impact factor: 3.307

4.  Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.

Authors:  D Adams; T Kuntzer; A J Steck; A Lobrinus; R C Janzer; F Regli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

5.  Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?

Authors:  M Weller; A Stevens; N Sommer; J Dichgans; B Kappler; H Wiethölter
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

Review 6.  Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery.

Authors:  Rachel Rios; Albina Jablonka-Shariff; Curtis Broberg; Alison K Snyder-Warwick
Journal:  Mol Cell Neurosci       Date:  2021-01-08       Impact factor: 4.314

7.  A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.

Authors:  N Yuki; T Taki; F Inagaki; T Kasama; M Takahashi; K Saito; S Handa; T Miyatake
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.